Register entry
IBSA Institut Biochimique SA
- Registered sites
- 1
- Drug products
- 0
- Live patents
- 81
- Countries
- 1
- Base
- Switzerland
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| IBSA Institut Biochimique SA | PazzalloSwitzerland | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3002864272 |
Exclusivity
Patents
81Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| LICART | DICLOFENAC EPOLAMINE | Feb 2035 |
| TIROSINT | LEVOTHYROXINE SODIUM | Sept 2044 |
| TIROSINT-SOL | LEVOTHYROXINE SODIUM | Feb 2037 |
| TIROSINT-SOL | LEVOTHYROXINE SODIUM | Sept 2039 |
| TIROSINT-SOL | LEVOTHYROXINE SODIUM | Sept 2044 |
| VYBRIQUE | SILDENAFIL CITRATE | Dec 2033 |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.